The 8th ImmunoTherapy of Cancer Conference, Virtual Conference, Austria, 08/10/2021- 09/10/2021
has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®)
with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit
that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Ethical MedTech Compliance
The 8th ImmunoTherapy of Cancer Conference adheres to the Code of Practice and supports the Eucomed Guidelines on Interactions with Healthcare Professionals (EthicalMedTech).
Please click here:
Ethical Med Tech: Conference Vetting System
The Conference Vetting System is a centralised decision-making system that encourages transparency and consistency in medical conferences and alleviates the complex administrative burden previously faced by Eucomed members, who were constrained to make their own determinations on whether or not a conference is compliant with the Code.
For further details please visit the Ethical MedTech Website